Matches in Wikidata for { <http://www.wikidata.org/entity/Q91010213> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q91010213 description "2018 թվականի օգոստոսի 11-ին հրատարակված գիտական հոդված" @default.
- Q91010213 description "article scientifique publié en 2018" @default.
- Q91010213 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91010213 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91010213 description "scientific article published on 11 August 2018" @default.
- Q91010213 description "wetenschappelijk artikel" @default.
- Q91010213 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91010213 name "CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML" @default.
- Q91010213 name "CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML" @default.
- Q91010213 type Item @default.
- Q91010213 label "CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML" @default.
- Q91010213 label "CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML" @default.
- Q91010213 prefLabel "CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML" @default.
- Q91010213 prefLabel "CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML" @default.
- Q91010213 P1433 Q91010213-C1BEB89E-9FDE-44A2-96FE-2A7752BDBF3A @default.
- Q91010213 P1476 Q91010213-F9680D10-90F6-4F40-83FD-E238B13E45F6 @default.
- Q91010213 P2093 Q91010213-09E12120-64B2-4967-8B04-C6E694377C72 @default.
- Q91010213 P2093 Q91010213-346782BF-7584-4DCA-A840-C37BE3DDC9B6 @default.
- Q91010213 P2093 Q91010213-5ADC844A-AC77-468B-93B4-661D7539B995 @default.
- Q91010213 P2093 Q91010213-71661E1A-A4FE-45AB-9167-9B39309606F0 @default.
- Q91010213 P2093 Q91010213-91549F83-A496-4D1F-8F5F-B9C0873F66D1 @default.
- Q91010213 P2093 Q91010213-95ED40A3-9867-48F6-B23E-3A37C58813A4 @default.
- Q91010213 P2093 Q91010213-A007EA4F-3BB1-4F8A-B4B8-F2E1625D907C @default.
- Q91010213 P2093 Q91010213-A84BA8E5-056F-4333-B58D-3AEA4947676C @default.
- Q91010213 P2860 Q91010213-AC023EF4-3411-4DEE-98E1-22E34A33C4A9 @default.
- Q91010213 P304 Q91010213-FDBA8441-DAAF-46E0-A0CC-698B10E196BD @default.
- Q91010213 P31 Q91010213-063572BB-781F-42F4-A26C-B1621D7C8DF5 @default.
- Q91010213 P356 Q91010213-751D4284-D464-450C-BCCA-E0F0CA0AE0F7 @default.
- Q91010213 P478 Q91010213-A20902BE-2714-4860-A5DA-2031C13BA838 @default.
- Q91010213 P50 Q91010213-58C98BE4-B54F-455F-996B-2781A3FB9144 @default.
- Q91010213 P577 Q91010213-BB084944-D11B-4F68-A12B-E68B84D2256D @default.
- Q91010213 P698 Q91010213-527A60C5-F252-4F52-B985-938EECE7CD4F @default.
- Q91010213 P356 J.LEUKRES.2018.08.007 @default.
- Q91010213 P698 30119908 @default.
- Q91010213 P1433 Q15716445 @default.
- Q91010213 P1476 "CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML" @default.
- Q91010213 P2093 "Barbara Rees" @default.
- Q91010213 P2093 "Darren Reynolds" @default.
- Q91010213 P2093 "Gareth Robinson" @default.
- Q91010213 P2093 "Heather Bone" @default.
- Q91010213 P2093 "Jonathan Heywood" @default.
- Q91010213 P2093 "Lawrence Mayer" @default.
- Q91010213 P2093 "Priyanka Mehta" @default.
- Q91010213 P2093 "Vyv Salisbury" @default.
- Q91010213 P2860 Q28276146 @default.
- Q91010213 P304 "121-129" @default.
- Q91010213 P31 Q13442814 @default.
- Q91010213 P356 "10.1016/J.LEUKRES.2018.08.007" @default.
- Q91010213 P478 "74" @default.
- Q91010213 P50 Q91010210 @default.
- Q91010213 P577 "2018-08-11T00:00:00Z" @default.
- Q91010213 P698 "30119908" @default.